NES and metastatic malignant neoplasm in the lymph nodes: Nestin positivity was observed in 15.8% of patients; positivity was significantly associated with SCCs, poor differentiation, intratumoral vascular invasion, lymph node metastasis, intratumoral lymphatic invasion, pleural invasion, and a poor prognosis.